SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|
| TAMBOCOR 100MG TAB | 100 mg | Tablet · Oral use | 60 Blister | SAR 59.05 | NCE · Prescription | 3M | Invalid · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | AMNEAL PHARM | Prescription | 31 Jul 2001 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | ANI PHARMS | Prescription | 28 Oct 2002 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | HIKMA PHARMS | Prescription | 14 Jan 2003 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | SUN PHARM INDS LTD | Prescription | 28 Mar 2003 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 3 Nov 2017 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | REGCON HOLDINGS | Prescription | 16 Sep 2020 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | YICHANG HUMANWELL | Prescription | 8 Sep 2022 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | MICRO LABS | Prescription | 22 Apr 2026 |
| TAMBOCOR | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | ALVOGEN | Discontinued | 31 Oct 1985 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | ANI PHARMS | Discontinued | 28 Oct 2002 |
| FLECAINIDE ACETATE | 50MG; 100MG; 150MG | tablet · oral | CHARTWELL | Discontinued | 9 Jul 2009 |
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|
| US NADAC | FLECAINIDE ACETATE 100 MG TAB | $0.17126 | per EA | 23 Sep 2026 |
| US NADAC | FLECAINIDE ACETATE 150 MG TAB | $0.26903 | per EA | 23 Sep 2026 |
| US NADAC | FLECAINIDE ACETATE 50 MG TAB | $0.10844 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Flecainide 100mg tablets | £4.96 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Flecainide 50mg tablets | £2.73 | 60 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.